Pacira BioSciences, Inc. (PCRX)
Across 62 earnings reports since Mar 31, 2011, Pacira BioSciences, Inc. (PCRX) has a clear post-earnings pattern. It moves ±4.68% on average after reporting and finishes higher 56.5% of the time. Its largest post-earnings gain was +19.43% (Oct 27, 2015) and its largest decline was -16.61% (Apr 30, 2015). The next earnings report is predicted for 2026-07-17 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
62
Avg Abs. Movement
±4.68%
Positive %
56.5%
Negative %
43.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | ☽ POST | $25.20 | $26.27 | $25.49 | 1,030,633 | -4% | open_in_new |
| Feb 26, 2026 | ☽ POST | $23.44 | $23.73 | $22.59 | 2,098,700 | -3.01% | open_in_new |
| Nov 06, 2025 | ☽ POST | $21.83 | $21.98 | $21.10 | 980,700 | +4.5% | open_in_new |
| Aug 05, 2025 | ☽ POST | $22.78 | $22.80 | $22.54 | 902,100 | -0.62% | open_in_new |
| May 08, 2025 | ☽ POST | $25.02 | $25.31 | $24.91 | 777,300 | +0.84% | open_in_new |
| Feb 27, 2025 | ☽ POST | $25.34 | $26.10 | $25.38 | 761,600 | -5.24% | open_in_new |
| Nov 06, 2024 | ☽ POST | $18.01 | $18.30 | $17.67 | 728,300 | +0.17% | open_in_new |
| Jul 30, 2024 | ☽ POST | $20.34 | $20.54 | $19.54 | 978,600 | +5.68% | open_in_new |
| May 07, 2024 | ☽ POST | $26.75 | $27.27 | $26.51 | 734,500 | +11.84% | open_in_new |
| Feb 29, 2024 | ☀ PRE | $29.45 | $30.52 | $29.72 | 768,400 | -0.64% | open_in_new |
| Nov 02, 2023 | ☀ PRE | $28.30 | $29.38 | $29.19 | 935,900 | +3.11% | open_in_new |
| Aug 02, 2023 | ☀ PRE | $34.75 | $37.40 | $36.71 | 1,351,800 | +1.97% | open_in_new |
| May 03, 2023 | ☀ PRE | $44.38 | $45.45 | $43.12 | 1,784,300 | -7.17% | open_in_new |
| Feb 28, 2023 | ☀ PRE | $41.64 | $44.53 | $42.57 | 1,632,900 | +3.93% | open_in_new |
| Dec 13, 2022 | ☀ PRE | $46.35 | $46.35 | $42.48 | 2,640,900 | -6.64% | open_in_new |
| Sep 13, 2022 | ☀ PRE | $54.76 | $56.47 | $56.01 | 399,300 | -0.2% | open_in_new |
| Jun 14, 2022 | ☀ PRE | $54.66 | $54.89 | $51.49 | 1,166,200 | -5.8% | open_in_new |
| Mar 15, 2022 | ☀ PRE | $71.00 | $71.28 | $70.59 | 535,100 | +0.09% | open_in_new |
| Dec 07, 2021 | ☀ PRE | $54.80 | $58.32 | $56.80 | 916,000 | +4.99% | open_in_new |
| Sep 15, 2021 | ☀ PRE | $54.74 | $56.13 | $55.18 | 473,500 | +0.99% | open_in_new |
| Jun 08, 2021 | ☀ PRE | $62.07 | $62.12 | $60.79 | 363,500 | -1.44% | open_in_new |
| Mar 09, 2021 | ☀ PRE | $71.88 | $72.20 | $70.73 | 288,300 | +0.23% | open_in_new |
| Dec 09, 2020 | ☀ PRE | $61.35 | $61.35 | $56.70 | 798,400 | -7.41% | open_in_new |
| Sep 09, 2020 | ☀ PRE | $60.50 | $62.42 | $60.03 | 845,700 | -0.1% | open_in_new |
| May 07, 2020 | ☀ PRE | $44.16 | $44.68 | $42.35 | 727,200 | +1.46% | open_in_new |
| Feb 20, 2020 | ☀ PRE | $51.30 | $51.30 | $50.02 | 1,418,700 | -1.34% | open_in_new |
| Nov 07, 2019 | ☀ PRE | $38.21 | $43.11 | $42.62 | 747,900 | +2.45% | open_in_new |
| Aug 08, 2019 | ☀ PRE | $45.50 | $45.50 | $42.36 | 1,508,700 | -3.38% | open_in_new |
| May 02, 2019 | ☀ PRE | $44.80 | $48.04 | $47.93 | 1,975,000 | +3.63% | open_in_new |
| Feb 28, 2019 | ☀ PRE | $44.00 | $45.42 | $41.18 | 1,834,700 | +1.35% | open_in_new |
| Nov 01, 2018 | ☀ PRE | $50.45 | $52.67 | $52.16 | 1,401,600 | +6.69% | open_in_new |
| Aug 02, 2018 | ☀ PRE | $41.65 | $43.63 | $43.00 | 1,370,100 | +5.91% | open_in_new |
| May 03, 2018 | ☀ PRE | $33.05 | $34.90 | $33.10 | 1,118,700 | -3.72% | open_in_new |
| Feb 28, 2018 | ☀ PRE | $31.80 | $32.65 | $31.30 | 1,251,400 | +0.32% | open_in_new |
| Nov 08, 2017 | ☀ PRE | $39.50 | $43.60 | $41.00 | 2,743,900 | +16.98% | open_in_new |
| Aug 02, 2017 | ☀ PRE | $37.90 | $40.30 | $38.40 | 1,508,700 | -1.92% | open_in_new |
| May 04, 2017 | ☀ PRE | $45.50 | $47.65 | $46.80 | 1,132,700 | +2.18% | open_in_new |
| Mar 01, 2017 | ☀ PRE | $56.50 | $58.95 | $49.55 | 5,990,800 | +13.39% | open_in_new |
| Nov 02, 2016 | ☀ PRE | $32.75 | $34.00 | $33.35 | 1,006,800 | +3.73% | open_in_new |
| Aug 04, 2016 | ☀ PRE | $41.99 | $45.98 | $44.63 | 3,627,900 | +19.05% | open_in_new |
| May 02, 2016 | ☀ PRE | $54.01 | $55.54 | $50.51 | 2,805,700 | -6.65% | open_in_new |
| Feb 25, 2016 | ☀ PRE | $55.05 | $61.92 | $57.26 | 1,422,500 | -3.94% | open_in_new |
| Oct 27, 2015 | ☀ PRE | $47.15 | $51.25 | $49.12 | 2,873,900 | +19.43% | open_in_new |
| Jul 30, 2015 | ☀ PRE | $58.00 | $66.24 | $61.80 | 2,383,700 | +5.28% | open_in_new |
| Apr 30, 2015 | ☀ PRE | $77.38 | $77.38 | $68.48 | 5,221,800 | -16.61% | open_in_new |
| Feb 24, 2015 | ☀ PRE | $120.00 | $121.78 | $115.11 | 614,400 | -2.48% | open_in_new |
| Oct 30, 2014 | ☀ PRE | $98.62 | $99.14 | $91.11 | 3,903,000 | -13.89% | open_in_new |
| Jul 31, 2014 | ☀ PRE | $91.01 | $93.98 | $92.00 | 1,234,700 | +4.75% | open_in_new |
| May 01, 2014 | ☀ PRE | $68.91 | $72.35 | $72.22 | 768,200 | +5.45% | open_in_new |
| Feb 25, 2014 | ☀ PRE | $78.00 | $83.41 | $78.14 | 987,500 | +6.56% | open_in_new |
| Oct 31, 2013 | ☀ PRE | $48.44 | $50.51 | $50.51 | 920,500 | +3.95% | open_in_new |
| Aug 06, 2013 | ☀ PRE | $34.94 | $36.79 | $36.56 | 441,400 | +4.28% | open_in_new |
| May 08, 2013 | ☀ PRE | $25.78 | $26.82 | $25.84 | 1,755,600 | -4.3% | open_in_new |
| Mar 07, 2013 | ☀ PRE | $26.05 | $26.25 | $26.10 | 436,400 | +0.69% | open_in_new |
| Nov 01, 2012 | ☀ PRE | $16.16 | $16.49 | $15.88 | 576,000 | +0.95% | open_in_new |
| Aug 09, 2012 | ☀ PRE | $15.31 | $16.79 | $16.20 | 526,900 | +8.43% | open_in_new |
| May 09, 2012 | ☀ PRE | $10.49 | $10.49 | $10.18 | 186,000 | -3.69% | open_in_new |
| Mar 27, 2012 | ☀ PRE | $11.63 | $11.92 | $11.59 | 186,300 | -0.26% | open_in_new |
| Oct 31, 2011 | ☀ PRE | $10.94 | $11.05 | $9.78 | 2,576,200 | -3.93% | open_in_new |
| Aug 11, 2011 | ☀ PRE | $8.86 | $9.27 | $9.05 | 84,200 | +2.61% | open_in_new |
| May 11, 2011 | ☀ PRE | $10.73 | $10.74 | $10.34 | 45,000 | -3% | open_in_new |
| Mar 31, 2011 | ☽ POST | $7.49 | $7.59 | $7.10 | 71,400 | -0.99% | open_in_new |
Earnings Count
62
Total earnings in dataset
Avg Abs. Movement
±4.68%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| DEFA14A | 20260604 | open_in_new SEC.gov |
| DEFA14A | 20260601 | open_in_new SEC.gov |
| DEFA14A | 20260528 | open_in_new SEC.gov |
| DFAN14A | 20260528 | open_in_new SEC.gov |
| DEFA14A | 20260527 | open_in_new SEC.gov |
| DEFA14A | 20260526 | open_in_new SEC.gov |
Frequently asked about PCRX earnings
When does Pacira BioSciences, Inc. report earnings next? expand_more
Pacira BioSciences, Inc. (PCRX)'s next earnings date is approximate for 2026-07-17. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does PCRX stock move after earnings? expand_more
Over 62 reports, PCRX has moved an average of ±4.68% the session after earnings, closing higher 56.5% of the time.
What was PCRX's biggest post-earnings move? expand_more
PCRX's largest post-earnings gain on record was +19.43% on Oct 27, 2015, and its largest decline was -16.61% on Apr 30, 2015.
Where can I find Pacira BioSciences, Inc.'s SEC filings? expand_more
All of Pacira BioSciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right